| Dr Manasa Madhuri Metireddy, MD | |
|
10 Barnes West Dr, Div Im Nephrology, Ste 200, Saint Louis, MO 63141-6287 | |
| (314) 362-7603 | |
| (314) 747-5213 |
| Full Name | Dr Manasa Madhuri Metireddy |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 18 Years |
| Location | 10 Barnes West Dr, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023269701 | NPI | - | NPPES |
| 200016352 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 2013015504 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North County Dialysis Center | Florissant, MO | Dialysis facility |
| Florissant Dialysis | Ferguson, MO | Dialysis facility |
| St Louis Dialysis | Saint louis, MO | Dialysis facility |
| North Saint Louis County Dialysis | Florissant, MO | Dialysis facility |
| Christian Hospital Northeast | Saint louis, MO | Hospital |
| Barnes Jewish Hospital | Saint louis, MO | Hospital |
| Barnes-jewish West County Hospital | Creve coeur, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington University | 9830008770 | 2506 |
News Archive
Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today praised the Federal Bureau of Investigation's (FBI) announcement that it will re-evaluate the requirements for outsourcing forensic DNA testing to private laboratories.
International research involving the University of Adelaide has uncovered a developmental abnormality in babies - especially in premature babies and in boys - that for the first time has been directly linked to cases of sudden infant death syndrome (SIDS).
The site, which is supposed to make transparent payments between drugmakers and physicians, is slated to be made public by Sept. 30. But as the deadline nears, the pharmaceutical industry is pressing the Centers for Medicare & Medicaid Services to be more transparent in explaining what's going on with the database.
Scarab Genomics announced a strategic agreement today with CellMed AG, a BTG International group company, in which CellMed AG will use Scarab Genomics' Clean Genome E. coli Technology in a new product development in the life science field.
BioVentrix, developer of the PliCath HF System, today announced the achievement of a significant milestone - completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).
› Verified 4 days ago
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841221116 PECOS PAC ID: 9830008770 Enrollment ID: O20031107000074 |
News Archive
Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today praised the Federal Bureau of Investigation's (FBI) announcement that it will re-evaluate the requirements for outsourcing forensic DNA testing to private laboratories.
International research involving the University of Adelaide has uncovered a developmental abnormality in babies - especially in premature babies and in boys - that for the first time has been directly linked to cases of sudden infant death syndrome (SIDS).
The site, which is supposed to make transparent payments between drugmakers and physicians, is slated to be made public by Sept. 30. But as the deadline nears, the pharmaceutical industry is pressing the Centers for Medicare & Medicaid Services to be more transparent in explaining what's going on with the database.
Scarab Genomics announced a strategic agreement today with CellMed AG, a BTG International group company, in which CellMed AG will use Scarab Genomics' Clean Genome E. coli Technology in a new product development in the life science field.
BioVentrix, developer of the PliCath HF System, today announced the achievement of a significant milestone - completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).
› Verified 4 days ago
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992746903 PECOS PAC ID: 9830008770 Enrollment ID: O20031119000372 |
News Archive
Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today praised the Federal Bureau of Investigation's (FBI) announcement that it will re-evaluate the requirements for outsourcing forensic DNA testing to private laboratories.
International research involving the University of Adelaide has uncovered a developmental abnormality in babies - especially in premature babies and in boys - that for the first time has been directly linked to cases of sudden infant death syndrome (SIDS).
The site, which is supposed to make transparent payments between drugmakers and physicians, is slated to be made public by Sept. 30. But as the deadline nears, the pharmaceutical industry is pressing the Centers for Medicare & Medicaid Services to be more transparent in explaining what's going on with the database.
Scarab Genomics announced a strategic agreement today with CellMed AG, a BTG International group company, in which CellMed AG will use Scarab Genomics' Clean Genome E. coli Technology in a new product development in the life science field.
BioVentrix, developer of the PliCath HF System, today announced the achievement of a significant milestone - completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).
› Verified 4 days ago
| Entity Name | Southeastern Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083835441 PECOS PAC ID: 0042307852 Enrollment ID: O20160809000235 |
News Archive
Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today praised the Federal Bureau of Investigation's (FBI) announcement that it will re-evaluate the requirements for outsourcing forensic DNA testing to private laboratories.
International research involving the University of Adelaide has uncovered a developmental abnormality in babies - especially in premature babies and in boys - that for the first time has been directly linked to cases of sudden infant death syndrome (SIDS).
The site, which is supposed to make transparent payments between drugmakers and physicians, is slated to be made public by Sept. 30. But as the deadline nears, the pharmaceutical industry is pressing the Centers for Medicare & Medicaid Services to be more transparent in explaining what's going on with the database.
Scarab Genomics announced a strategic agreement today with CellMed AG, a BTG International group company, in which CellMed AG will use Scarab Genomics' Clean Genome E. coli Technology in a new product development in the life science field.
BioVentrix, developer of the PliCath HF System, today announced the achievement of a significant milestone - completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).
› Verified 4 days ago
| Entity Name | Ipc Pac Healthcare Services Of Missouri Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326497587 PECOS PAC ID: 4587950589 Enrollment ID: O20160830002898 |
News Archive
Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today praised the Federal Bureau of Investigation's (FBI) announcement that it will re-evaluate the requirements for outsourcing forensic DNA testing to private laboratories.
International research involving the University of Adelaide has uncovered a developmental abnormality in babies - especially in premature babies and in boys - that for the first time has been directly linked to cases of sudden infant death syndrome (SIDS).
The site, which is supposed to make transparent payments between drugmakers and physicians, is slated to be made public by Sept. 30. But as the deadline nears, the pharmaceutical industry is pressing the Centers for Medicare & Medicaid Services to be more transparent in explaining what's going on with the database.
Scarab Genomics announced a strategic agreement today with CellMed AG, a BTG International group company, in which CellMed AG will use Scarab Genomics' Clean Genome E. coli Technology in a new product development in the life science field.
BioVentrix, developer of the PliCath HF System, today announced the achievement of a significant milestone - completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).
› Verified 4 days ago
| Entity Name | St Charles Physician Services Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609317205 PECOS PAC ID: 5698052694 Enrollment ID: O20170428002056 |
News Archive
Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today praised the Federal Bureau of Investigation's (FBI) announcement that it will re-evaluate the requirements for outsourcing forensic DNA testing to private laboratories.
International research involving the University of Adelaide has uncovered a developmental abnormality in babies - especially in premature babies and in boys - that for the first time has been directly linked to cases of sudden infant death syndrome (SIDS).
The site, which is supposed to make transparent payments between drugmakers and physicians, is slated to be made public by Sept. 30. But as the deadline nears, the pharmaceutical industry is pressing the Centers for Medicare & Medicaid Services to be more transparent in explaining what's going on with the database.
Scarab Genomics announced a strategic agreement today with CellMed AG, a BTG International group company, in which CellMed AG will use Scarab Genomics' Clean Genome E. coli Technology in a new product development in the life science field.
BioVentrix, developer of the PliCath HF System, today announced the achievement of a significant milestone - completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).
› Verified 4 days ago
| Entity Name | Forest Physician Services, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548791676 PECOS PAC ID: 8325325202 Enrollment ID: O20170502000753 |
News Archive
Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today praised the Federal Bureau of Investigation's (FBI) announcement that it will re-evaluate the requirements for outsourcing forensic DNA testing to private laboratories.
International research involving the University of Adelaide has uncovered a developmental abnormality in babies - especially in premature babies and in boys - that for the first time has been directly linked to cases of sudden infant death syndrome (SIDS).
The site, which is supposed to make transparent payments between drugmakers and physicians, is slated to be made public by Sept. 30. But as the deadline nears, the pharmaceutical industry is pressing the Centers for Medicare & Medicaid Services to be more transparent in explaining what's going on with the database.
Scarab Genomics announced a strategic agreement today with CellMed AG, a BTG International group company, in which CellMed AG will use Scarab Genomics' Clean Genome E. coli Technology in a new product development in the life science field.
BioVentrix, developer of the PliCath HF System, today announced the achievement of a significant milestone - completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manasa Madhuri Metireddy, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 362-7603 | Dr Manasa Madhuri Metireddy, MD 10 Barnes West Dr, Div Im Nephrology, Ste 200, Saint Louis, MO 63141-6287 Ph: (314) 362-7603 |
News Archive
Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today praised the Federal Bureau of Investigation's (FBI) announcement that it will re-evaluate the requirements for outsourcing forensic DNA testing to private laboratories.
International research involving the University of Adelaide has uncovered a developmental abnormality in babies - especially in premature babies and in boys - that for the first time has been directly linked to cases of sudden infant death syndrome (SIDS).
The site, which is supposed to make transparent payments between drugmakers and physicians, is slated to be made public by Sept. 30. But as the deadline nears, the pharmaceutical industry is pressing the Centers for Medicare & Medicaid Services to be more transparent in explaining what's going on with the database.
Scarab Genomics announced a strategic agreement today with CellMed AG, a BTG International group company, in which CellMed AG will use Scarab Genomics' Clean Genome E. coli Technology in a new product development in the life science field.
BioVentrix, developer of the PliCath HF System, today announced the achievement of a significant milestone - completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).
› Verified 4 days ago
Dr. Isik Turker, MD Nephrology Medicare: Medicare Enrolled Practice Location: 4921 Parkview Pl, Div Im Cardiology, Ste 8b, Saint Louis, MO 63110 Phone: 314-362-1291 Fax: 314-362-4278 | |
Conor Mccartney, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 915 N Grand Blvd, Saint Louis, MO 63106 Phone: 314-652-4100 | |
Dr. Faris Adam Bakeer, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Rehan Rais, M.D. M.B.,B.S. Nephrology Medicare: Medicare Enrolled Practice Location: 660 S Euclid Ave, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Nathan Farkas, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1 Barnes Jew Hosp Plz, Saint Louis, MO 63110 Phone: 314-362-1930 | |
Dr. Nicole Foley, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Soumojit Ghosh, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3660 Vista Ave, Saint Louis, MO 63110 Phone: 314-977-6100 Fax: 314-977-6164 |